All
  • All
  • ELISA Kit
  • Protein
  • Antibody
  • Molecular Biology Product
  • Small Molecule
  • Raw Material For IVD Kit
All
  • All
  • ELISA Kit
  • Protein
  • Antibody
  • Molecular Biology Product
  • Small Molecule
  • Raw Material For IVD Kit

Bovine Immunoglobulin G,IgG ELISA Kit

Citations (6)
Code CSB-E12015B
Size 96T,5×96T,10×96T
Trial Size 24T ELISA kits trial application
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Abbreviation IgG
Species Bos taurus (Bovine)
Sample Types serum, plasma
Detection Range 78 ng/ml-5000ng/ml
Sensitivity 19.5 ng/ml
Assay Time 1-5h
Sample Volume 50-100ul
Detection Wavelength 450 nm
Research Area Immunology
Assay Principle quantitative
Measurement Competitive
ELISA Data Analysis Watch ELISA data processing video & download Curve Expert if needed
Troubleshooting
and FAQs		 ELISA kit FAQs
Storage Store at 2-8°C. Please refer to protocol.
Lead Time 3-5 working days

Citations

Related Products

ELISA kits

Customer Reviews and Q&A

■ Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Promotions
Contact Us

  Email: [email protected]
  Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

Related Articles
TWIK2 channel mediates inflammation, study finds Osteoprotegerin (OPG): What is Its Potential as a Biomarker or Therapeutic Target? Histones and Their Roles in Diseases Does Antibody-dependent Enhancement Occur in SARS-CoV-2 Infection? MUC16 (CA125): a Promising Predictive Marker and Therapeutic Target in Cancer EGFR and Its Application in Cancer Therapy An Overview of Cell Death: Necrosis and Apoptosis TNFRSF9: A Potent Immune-Stimulator in Cancer GCGR: A Regulator of Energy Balance Holds a Potential in Treatment Diabetes TNFR1: A Multifaceted Molecule in Cancer, Another Promising Therapeutic Target for COVID-19 NRG1: an Intriguing Therapeutic Target in Diseases C5AR1: A Potential Molecule of Complement System to Fuel COVID-19 Therapy! Lysosomal Enzymes and Lysosomal Storage Disorders (LSDs) 2021 Insights on the CAR-T Cell Therapy: the Most Popular Targets for Solid Tumor! Cellular Senescence and Its Markers CD24: A New Treatment EXO-CD24 via "Tiny Carriers" Exosomes to Resist COVID-19? DLL3: A New Molecular Target in Cancer How to Choose? Polyclonal, Monoclonal, or Recombinant Antibody? DNA Damage and Repair TFPI: a Natural Anticoagulant Protein, Future Therapies for Hemophilia DT3C, a Powerful Tool for ADC Drug Internalization In Vitro CLDN6: A "New Favorite" in Targeted Cancer Therapy after CLDN 18.2! RSPO1: The key factor determining "battle of the sexes " is “favored” in the culture of organoids? CD93, A Rising Star in Anti-Tumor Therapy GPRC5D: Newly Efficient GPRC5D CAR-T or Bispecific Antibody Therapy to Fight Multiple Myeloma (MM) The Collection of Progress of Anti-GPCR Antibody Drugs Dual Role of TNFRSF14 in Immunology With the High Potential in Cancer Immunotherapy, CD40 Is Triggering Attention CD14-- A Membrane Receptor for Bacterial Lipopolysaccharides ERBB3/HER3: a New Target for Tumor Therapy, a Driver Gene of Multi-Tumors How Do You Get Exosomes? Cell Differentiation Determines the Fate of Cells CD73, What a Powerful Therapy Target in Tumor Immune A Resume for Transmembrane Proteins Categories over 10000! --Rare diseases that are no longer "rare" G protein-Coupled Receptor - Targets for Drug Therapy Tuberculosis--A Resurgent "White Plague" A Review of WFDC8 Antibody Costimulatory/Coinhibitory: Is B7-H3 An Enemy or A Friend? The Overview of Fc Receptors- Classification, Related Signaling Pathways and Application Effects of FSHR on Fertility and Tumors The Overview of Recombinant Antibody Chemokine Receptors – One Kind of Powerful Seven Transmembrane Spanning G Protein-coupled Receptor How to Choose the Right Secondary Antibody? Understanding Hepatitis, Fighting Hepatitis Leukemia, Why is it So Common? Biological Activity of Proteins The Metabolic Phenotype of Tumor-Associated Macrophages in the Tumor Microenvironment The Rare Disease-Huntington's Disease Nanobody, what a Powerful Novel Antibody! The Application of IHC in Pathological Diagnosis LPS/TLR4 Signal Transduction Pathway Toll-like Receptors--The Eye of Innate Immunity The difference between primary antibody and secondary antibody CD46, A Complement Regulator The Meaning of Irregular Antibody Screening What Factors Could Affect ELISA Results? A "trembling" Parkinson's Disease Focus on Emerging Therapeutic Targets BCMA CD20 Monoclonal Antibodies Drugs: There is an Explosion of New mAbs Against CD20! Tumor Necrosis Factor Receptor Superfamily and Apoptosis The Overview of Coagulation Monoclonal Antibody Drugs Overview SLC39A6/ZIP6: a Key Member of Zinc Transporters, a Novel Targeting Antigen of ADC! CD44- A Powerful Bridge Between Cells How do Th1 and Th2 Cells Differentiate? CD22- What A Powerful Co-receptor of B Cell Receptor TCGA Database- A Good Partner of Researchers Four Common Histone Modifications The Multifunctional Enzyme CD38: A Target for Immunotherapeutic Approaches in Cancer What A Paradoxical TNF Signaling Pathway-Based on Different Receptors CD146, A Powerful Tumor Marker GPCR Drugs Discovery Introduction of Hepatocellular Carcinoma Related Signaling Pathways Mesothelin: A Rising Star of Cancer Immunotherapy Diabetes: What You Need to Know ACE2, The Hottest Target of SARS-CoV-2 Invasion Epitope Tags Overview Please Take It Seriously-Influenza An Overview of CD226 and Its Promising Role in Cancer Immunotherapy TROP2-An Important Target for Cancer Treatment OMA1-A Potential Cancer Therapy Target CD Antigens - From Leucocytes Surface Markers to Diagnostic Markers for Cancer TASIN represents a promising approach for prevention of colorectal cancer Antibody ABTAA alters tumor blood vessels Surface Markers of Natural Killer Cells What Is an Antibody? LY6G6D (LY6-G): A New Member of Lymphocyte Antigen-6 Family Holds Big Opportunities in Bispecific Antibody for CRC Treatment! Exploring the Science of Influenza A Virus: What You Need to Know Modified red blood cells prevents harmful immune response BMTP-11 found to delay progression of osteosarcoma ANGPT2 (Ang-2): the First Bispecific Antibody for Eye Vision Loss Therapy, a Novel Target for Tumor Angiogenesis! The Overview of Chemokine A drug candidate holds promise in treating autism The Overview of Colony Stimulating Factors Apoptosis mediated by mitochondria Apoptosis mediated by endoplasmic reticulum Apoptosis mediated by death receptor Inhibition of ASCT2 combats cancer in vitro and in vivo EphA3-A Regulator of Cell Adhesion and Migration Itaconate is a negative regulator of inflammation Tumor Necrosis Factor (TNF) The Overview of Interferon A Group of Promising Proteins - Cell Cycle Markers The Overview of Interleukin The Overview of Autophagy The Overview of Phage Display：Protocol, Classification, Application and FAQs Crosstalk Between Autophagy and Apoptosis TTR: an Important Protein of Amyloidosis, Novel Therapies are Upcoming for Rare Diseases ATTR-CM and ATTR-PN! The Overview of Breast Cancer: Related Signaling Pathways, Therapeutic Targets The overview of Wnt signaling pathway Double-Edged Sword: TGF-β Do You Really Know TGF-β Superfamily? Bispecific Antibody Overview: From Definition to Application The Review of Post-translational Modifications CLDN3: Another Tight Junction Protein or New Drug Target, Interest in CLDN Family is Growing Fast! ELISA Data Analysis How to Do The Pre-experiment before Your ELISA Experiment Four Types of ELISA 11 tips for choosing your right ELISA kit Do you Often Trouble in These Problems of ELISA? Problems and Solutions in ELISA Experiments
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
Email
[email protected]
Address
7505 Fannin St Ste 610-322 Houston, TX 77054, USA
Join Us with

Subscribe newsletter

Leave a message

© 2007-2023 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1